Movers

MP Materials Sets Stage For Heavy Rare Earth Breakthrough In 2026

Posted on: Friday, November 7, 2025 - 1:28pm

MP Materials Corp. (NYSE: MP) rose on mixed quarterly results, with progress on domestic rare earth separation boosting long-term outlook.

All terms: Analyst Color, Equities, News, Price Target, Reiteration, Top Stories, Markets, Analyst Ratings, Movers, Trading Ideas, General

Flying-Taxi Maker Archer Loses Altitude As Investors Question Costly Airport Move

Posted on: Friday, November 7, 2025 - 1:27pm

Archer Aviation Inc. (NYSE: ACHR) shares down on Q3 results and plans to acquire Hawthorne Airport for $126 million.

All terms: Analyst Color, Earnings, Equities, News, Price Target, Reiteration, Top Stories, Analyst Ratings, Movers, Trading Ideas

Affirm Holdings Posts Q1 Beat, Is 'Firing On All Cylinders': Analysts

Posted on: Friday, November 7, 2025 - 1:26pm

Shares of Affirm Holdings climbed in early trading on Friday, after the company reported fiscal first-quarter results.

All terms: Analyst Color, Earnings, Earnings Beats, Price Target, Reiteration, Analyst Ratings, Movers

Take-Two Shares Fall After Rockstar Delays Grand Theft Auto VI

Posted on: Friday, November 7, 2025 - 1:07pm

Take-Two Interactive log on table with two gaming modules in front of it

Take-Two Interactive shares are trading lower after Rockstar delayed the release of Grand Theft Auto VI.

All terms: News, Movers

Nvidia, Palantir, AMD Stocks Had A Really Bad Week

Posted on: Friday, November 7, 2025 - 12:59pm

Hand holding needle near stock market bubble.

This week was brutal for AI stocks, Nvidia, Palantir and AMD. All suffered their steepest declines in months.

All terms: Large Cap, News, Movers, Tech, Trading Ideas

FDA Clears Johnson & Johnson's Darzalex Faspro, Enabling Early Intervention In Myeloma Progression

Posted on: Friday, November 7, 2025 - 12:57pm

The FDA approves Johnson & Johnson's Darzalex Faspro for high-risk smoldering multiple myeloma and Caplyta as an add-on therapy for major depressive disorder.

All terms: Biotech, Government, Large Cap, News, Health Care, FDA, Movers, Trading Ideas, General

Rivian Loses Steam on Mixed Signals; Trades Below Tesla

Posted on: Friday, November 7, 2025 - 12:56pm

Rivian shares fell on a mixed Q3—revenue beat ($1.56B, +78%) and first ex-credits gross profit ($24M) but cash-burn worries persist—as JPMorgan kept Underweight ($10), noting valuation below Tesla yet above Chinese BEVs.

All terms: Analyst Color, Equities, News, Price Target, Markets, Analyst Ratings, Movers, Trading Ideas, General

CyberArk Shows Strong Growth Ahead Of Palo Alto Networks Merger

Posted on: Friday, November 7, 2025 - 12:51pm

CyberArk (CYBR) reported strong Q3 results and expanding subscription revenue despite acquisition costs. DA Davidson maintains Buy rating.

All terms: Analyst Color, Earnings, News, Price Target, Reiteration, Top Stories, Analyst Ratings, Movers, Trading Ideas

Affirm Surges On Strong Results, Analyst Praise, Long-Term Amazon Pact

Posted on: Friday, November 7, 2025 - 12:41pm

Affirm Holdings (NASDAQ: AFRM) saw shares rise after beating earnings expectations and announcing an expanded partnership with Amazon.

All terms: Analyst Color, Earnings, Fintech, News, Price Target, Reiteration, Analyst Ratings, Movers, Trading Ideas

Eli Lilly's Investigational Obesity Drug Shows Up To 20% Weight Loss In Phase 2 Study, Analyst Sees It As Emerging Cornerstone In Obesity Treatment

Posted on: Friday, November 7, 2025 - 12:33pm

Eli Lilly's eloralintide cut body weight by up to 20% in a Phase 2 trial, showing strong efficacy and potential to advance obesity treatment.

All terms: Analyst Color, Biotech, Large Cap, News, Health Care, Analyst Ratings, Movers, Trading Ideas, General